Articles

Invest in the these seven best REITs to buy offering strong upside and shining bright in 2023's tough real estate market. More

NKLA stock is trending and tumbling after Nikola reported that it would offer a combined $300 million of stock and notes. More

Cerevel Therapeutics stock is climbing higher as CERE investors react to an $8.7 billion acquisition deal with AbbVie. More

Henrik Fisker called reports on his company's problems "overblown," but he has cut production to conserve working capital. More

Rivian stock is gaining on Thursday after Stifel weighed in on RIVN shares with a buy rating and set a price target of $23 per share. More

E-bike stocks are expected to soar in value over the next few decades. Here are the best companies to have on your watchlist. More

These three cryptos are worth a look or a buy in December for multiple reasons as the sector heats up amid tailwinds. More

Subscriber Sign in